Randomized Phase II Trial of Sulindac for Lung Cancer Chemoprevention

INTRODUCTION: Sulindac represents a promising candidate agent for lung cancer chemoprevention, but clinical trial data have not been previously reported. We conducted a randomized, phase II chemoprevention trial involving current or former cigarette smokers (≥ 30 pack-years) utilizing the multi-cent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Limburg, Paul J., Mandrekar, Sumithra J., Aubry, Marie Christine, Ziegler, Katie L. Allen, Zhang, Jun, Yi, Joanne E., Henry, Michael, Tazelaar, Henry D., Lam, Stephen, McWilliams, Annette, Midthun, David E., Edell, Eric S., Rickman, Otis B., Mazzone, Peter, Tockman, Melvyn, Beamis, John F., Lamb, Carla, Simoff, Michael, Loprinzi, Charles, Szabo, Eva, Jett, James
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3566344/
https://ncbi.nlm.nih.gov/pubmed/23261228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2012.11.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars